Home >> Signaling Pathways >> MAPK Signaling >> JNK

JNK

JNK (c-Jun N-terminal kinase) is a group of kinases belong to the mitogen-activated protein kinase family and also play a role in T cell differentiation and the cellular apoptosis pathway.

Products for  JNK

  1. Cat.No. Product Name Information
  2. GC60393 (-)-Zuonin A (-)-Zuonin A (D-Epigalbacin), a naturally occurring lignin, is a potent, selective JNKs inhibitor, with IC50s of 1.7 μM, 2.9 μM and 1.74 μM for JNK1, JNK2 and JNK3, respectively. (-)-Zuonin A  Chemical Structure
  3. GC63903 (E)-Osmundacetone (E)-Osmundacetone is the isomer of Osmundacetone. (E)-Osmundacetone  Chemical Structure
  4. GA20623 Ac-muramyl-Ala-D-Glu-NH₂ Ac-muramyl-Ala-D-Glu-NH₂ (MDP) is a synthetic immunoreactive peptide, consisting of N-acetyl muramic acid attached to a short amino acid chain of L-Ala-D-isoGln. Ac-muramyl-Ala-D-Glu-NH₂  Chemical Structure
  5. GC35242 Actein Actein is a triterpene glycoside isolated from the rhizomes of Cimicifuga foetida. Actein suppresses cell proliferation, induces autophagy and apoptosis through promoting ROS/JNK activation, and blunting AKT pathway in human bladder cancer. Actein has little toxicity in vivo. Actein  Chemical Structure
  6. GC10204 AEG 3482 inhibitor of Jun kinase (JNK)-dependent apoptosis AEG 3482  Chemical Structure
  7. GC11559 Anisomycin

    JNK agonist, potent and specific

    Anisomycin  Chemical Structure
  8. GC12882 AS 602801 A selective, orally bioavailable JNK inhibitor AS 602801  Chemical Structure
  9. GC10010 AS601245 A c-Jun NH2-terminal protein kinase inhibitor AS601245  Chemical Structure
  10. GN10494 Astragaloside IV Astragaloside IV  Chemical Structure
  11. GC12904 BI 78D3 Competitive JNK inhibitor BI 78D3  Chemical Structure
  12. GC10693 c-JUN peptide JNK/c-Jun interaction inhibitor c-JUN peptide  Chemical Structure
  13. GC50400 CC 401 dihydrochloride High affinity JNK inhibitor; also inhibits HCMV replication CC 401 dihydrochloride  Chemical Structure
  14. GC13529 CC-401 JNK inhibitor,ATP-competitive CC-401  Chemical Structure
  15. GC14197 CC-401 hydrochloride A potent, specific pan-JNK inhibitor CC-401 hydrochloride  Chemical Structure
  16. GC62492 CC-90001 CC-90001 is a potent, selective and orally active inhibitor of c-Jun N-terminal kinase (JNK). CC-90001  Chemical Structure
  17. GC10446 CC-930 A potent JNK inhibitor CC-930  Chemical Structure
  18. GC12841 CEP 1347 JNK inhibitor CEP 1347  Chemical Structure
  19. GC30057 D-JNKI-1 (AM-111) D-JNKI-1 (AM-111) (AM-111) is a highly potent and cell-permeable peptide inhibitor of JNK. D-JNKI-1 (AM-111)  Chemical Structure
  20. GC14114 DB07268 A potent inhibitor of JNK1 DB07268  Chemical Structure
  21. GC13244 DTP3 inhibitor of GADD45β/MKK7 complex DTP3  Chemical Structure
  22. GC38202 DTP3 TFA DTP3 TFA is a potent and selective GADD45β/MKK7 (growth arrest and DNA-damage-inducible β/mitogen-activated protein kinase kinase 7) inhibitor. DTP3 TFA targets an essential, cancer-selective cell-survival module downstream of the NF-κB pathway. DTP3 TFA  Chemical Structure
  23. GC36006 Esculentoside H Thalidomide-O-PEG4-amine is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. Esculentoside H  Chemical Structure
  24. GN10307 Ginsenoside Re Ginsenoside Re  Chemical Structure
  25. GC17658 Guggulsterone Broad spectrum steroid receptor ligand Guggulsterone  Chemical Structure
  26. GC25521 IMM-H007 IMM-H007, an adenosine derivative, is an activator of AMP-Activated Protein Kinase (AMPK). IMM-H007 is a potential drug for treating cardiac dysfunction. IMM-H007 negatively regulates endothelium inflammation through inactivating NF-κB and JNK/AP1 signaling. IMM-H007 inhibits ABCA1 (ATP binding cassette subfamily a member 1) degradation and facilitates its cell-surface localization in macrophages, thereby promotes cholesterol efflux. IMM-H007  Chemical Structure
  27. GC12674 IQ 3 Selective JNK3 inhibitor IQ 3  Chemical Structure
  28. GC36327 IQ-1S free acid An inhibitor of NF-κB/AP-1 IQ-1S free acid  Chemical Structure
  29. GN10804 Isovitexin Isovitexin  Chemical Structure
  30. GC33844 Isovitexin (Saponaretin) A C-glycosylated flavone with diverse biological activities Isovitexin (Saponaretin)  Chemical Structure
  31. GC36359 J30-8 J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC50 of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8  Chemical Structure
  32. GC13724 JIP-1 (153-163) Peptide inhibitor of c-Jun N-terminal kinase (JNK) JIP-1 (153-163)  Chemical Structure
  33. GC15028 JNK-IN-7 A non-selective JNK inhibitor JNK-IN-7  Chemical Structure
  34. GC13841 JNK-IN-8 JNK-IN-8 is the first irreversible inhibitor of JNK, targeting JNK1, JNK2, and JNK3 with IC50 values of 4.7 nM, 18.7 nM, and 1 nM, respectively, in the A375 cell line. JNK-IN-8  Chemical Structure
  35. GC32983 Juglanin Juglanin, a natural occurring flavonoid, is a JNK acticator, with inflammation and anti-tumor activities. Juglanin  Chemical Structure
  36. GC46015 KY 05009 A TNIK inhibitor KY 05009  Chemical Structure
  37. GC34275 L-JNKI-1 L-JNKI-1 is a cell-permeable peptide inhibitor specific for JNK. L-JNKI-1  Chemical Structure
  38. GC11157 LL-Z 1640-4 A signal-specific JNK/p38 pathway and TAK 1 inhibitor LL-Z 1640-4  Chemical Structure
  39. GN10267 Loureirin B Loureirin B  Chemical Structure
  40. GC49241 Methyl Diethyldithiocarbamate An active metabolite of disulfiram Methyl Diethyldithiocarbamate  Chemical Structure
  41. GC36652 MPT0B392 MPT0B392, an orally active quinoline derivative, induces c-Jun N-terminal kinase (JNK) activation, leading to apoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss and caspases cleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novel microtubule-depolymerizing agent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line. MPT0B392  Chemical Structure
  42. GC44587 PDMP (hydrochloride) PDMP is a ceramide analog first prepared in a search for inhibitors of glucosylceramide synthase. PDMP (hydrochloride)  Chemical Structure
  43. GC14938 PF-03394197(Oclacitinib) Novel Janus kinase inhibitor PF-03394197(Oclacitinib)  Chemical Structure
  44. GN10709 Polyphyllin A Polyphyllin A  Chemical Structure
  45. GC16652 SR 3576

    JNK3 inhibitor, potent and selective

    SR 3576  Chemical Structure
  46. GC30864 SR-3306 SR-3306 is a selective, potent, highly brain penetrant JNK inhibitor. SR-3306  Chemical Structure
  47. GC11542 SU 3327 JNK inhibitor SU 3327  Chemical Structure
  48. GC25982 Tanzisertib(CC-930) Tanzisertib (CC-930, JNK-930, JNKI-1) is kinetically competitive with ATP in the JNK-dependent phosphorylation of the protein substrate c-Jun and potent against all isoforms of JNK (Ki(JNK1) = 44 ± 3 nM, IC50(JNK1) = 61 nM, Ki(JNK2) = 6.2 ± 0.6 nM, IC50(JNK2) = 5 nM, IC50(JNK3) = 5 nM) and selective against MAP kinases ERK1 and p38a with IC50 of 0.48 and 3.4 μM respectively. Tanzisertib(CC-930)  Chemical Structure
  49. GC11488 TCS JNK 5a JNK2 and JNK3 inhibitor TCS JNK 5a  Chemical Structure
  50. GC17282 TCS JNK 6o TCS JNK 6o (TCS JNK 6o) is a c-Jun N-terminal kinases (JNK-1, -2, and -3) inhibitor with Ki values of 2 nM, 4 nM, 52 nM, respectively, and has IC50 values of 45 nM and 160 nM for JNK-1 and -2, respectively. TCS JNK 6o  Chemical Structure
  51. GC31647 Tomatidine Tomatidine acts as an anti-inflammatory agent by blocking NF-κB and JNK signaling. Tomatidine  Chemical Structure
  52. GC45064 Tomatidine (hydrochloride) Tomatidine is a steroidal alkaloid that has been found in the skins and leaves of tomatoes. Tomatidine (hydrochloride)  Chemical Structure
  53. GC38679 Urolithin B A metabolite of ellagic acid Urolithin B  Chemical Structure
  54. GC38053 WHI-P258 A negative control for JAK3 inhibition WHI-P258  Chemical Structure

53 Item(s)

per page

Set Descending Direction